Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: An animal study and a prospective case-control study

Anesthesiology

Volumn 122, Issue 4, 2015, Pages 852-863

  Wang, Jia Feng ^a   Li, Jin Bao ^a   Zhao, Yan Jun ^b   Yi, Wen Jing ^a   Bian, Jin Jun ^a   Wan, Xiao Jian ^a   Zhu, Ke Ming ^a   Deng, Xiao Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR2; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROGRAMMED DEATH 1 LIGAND 1; CD274 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; APOPTOSIS; ARTERY THROMBOSIS; ARTICLE; BONE MARROW; CANCER PATIENT; CASE CONTROL STUDY; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FISTULA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LYMPHOCYTE; MOUSE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PANCREAS FISTULA; PERCUTANEOUS NEPHROLITHOTOMY; PERITONEAL CAVITY; PHENOTYPE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SEPSIS; UPREGULATION; AGED; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANIMALS; ANTIGENS, CD274; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNE TOLERANCE; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEUTROPHILS; PROSPECTIVE STUDIES; SEPSIS; UP-REGULATION;

EID: 84932177596     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000525     Document Type: Article

References (33)

1. Lever A, Mackenzie I: Sepsis: Definition, epidemiology, and diagnosis. BMJ 2007; 335:879-83
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-54
3. Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, Fang Q, Xu Q, Wang D, Jin Y, Yuan S, Wang J, Du Z, Sun Y, Fang X: Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 2007; 35:2538-46
4. Seymour CW, Iwashyna TJ, Cooke CR, Hough CL, Martin GS: Marital status and the epidemiology and outcomes of sepsis. Chest 2010; 137:1289-96
5. Reinhart K, Menges T, Gardlund B, Harm Zwaveling J, Smithes M, Vincent JL, Tellado JM, Salgado-Remigio A, Zimlichman R, Withington S, Tschaikowsky K, Brase R, Damas P, Kupper H, Kempeni J, Eiselstein J, Kaul M: Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med 2001; 29:765-9
6. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995; 273:934-41
7. Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13:260-8
8. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA: The sepsis seesaw: Tilting toward immunosuppression. Nat Med 2009; 15:496-7
9. Keir ME, Butte MJ, Freeman GJ, Sharpe AH: PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26:677-704
10. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ: The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239-45
11. Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, Wan X, Deng X, Cai Z: PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care 2010; 14:R220
12. Zhang Y, Li J, Lou J, Zhou Y, Bo L, Zhu J, Zhu K, Wan X, Cai Z, Deng X: Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care 2011; 15:R70
13. Malcolm KC, Arndt PG, Manos EJ, Jones DA, Worthen GS: Microarray analysis of lipopolysaccharide-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol 2003; 284:L663-70
14. Bankey PE, Banerjee S, Zucchiatti A, De M, Sleem RW, Lin CF, Miller-Graziano CL, De AK: Cytokine induced expression of programmed death ligands in human neutrophils. Immunol Lett 2010; 129:100-7
15. McNab FW, Berry MP, Graham CM, Bloch SA, Oni T, Wilkinson KA, Wilkinson RJ, Kon OM, Banchereau J, Chaussabel D, O'Garra A: Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. Eur J Immunol 2011; 41:1941-7
16. de Kleijn S, Langereis JD, Leentjens J, Kox M, Netea MG, Koenderman L, Ferwerda G, Pickkers P, Hermans PW: IFN-stimulated neutrophils suppress lymphocyte proliferation througHexpression of PD-L1. PLoS One 2013; 8:e72249
17. Huang X, Chen Y, Chung CS, Yuan Z, Monaghan SF, Wang F, Ayala A: Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J Immunol 2014; 192:1091-9
18. Ostanin DV, Kurmaeva E, Furr K, Bao R, Hoffman J, Berney S, Grisham MB: Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis. J Immunol 2012; 188:1491-502
19. Culshaw S, Millington OR, Brewer JM, McInnes IB: Murine neutrophils present Class II restricted antigen. Immunol Lett 2008; 118:49-54
20. Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, Ulfman LH, Leenen LP, Pickkers P, Koenderman L: A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012; 122:327-36
21. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW III, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 2005; 24(suppl 1):52-7
22. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, Silva JS, Gazzinelli RT, Teixeira MM, Ferreira SH, Cunha FQ: Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci USA 2009; 106:4018-23
23. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6
24. Kansas GS, Muirhead MJ, Dailey MO: Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 1990; 76:2483-92
25. Schwartz M, Carlson R, Tipold A: Selective CD11a upregulation on neutrophils in the acute phase of steroid-responsive meningitis-arteritis in dogs. Vet Immunol Immunopathol 2008; 126:248-55
26. Souto FO, Alves-Filho JC, Turato WM, Auxiliadora-Martins M, Basile-Filho A, Cunha FQ: Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis. Am J Respir Crit Care Med 2011; 183:234-42
27. Fitrolaki DM, Dimitriou H, Kalmanti M, Briassoulis G: CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children. BMC Pediatr 2013; 13:31
28. Gerrits JH, McLaughlin PM, Nienhuis BN, Smit JW, Loef B: Polymorphic mononuclear neutrophils CD64 index for diagnosis of sepsis in postoperative surgical patients and critically ill patients. Clin Chem Lab Med 2013; 51:897-905
29. Gibot S, Béné MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho Bittencourt M, Quenot JP, Bollaert PE, Faure G, Charles PE: Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012; 186:65-71
30. Abi Abdallah DS, Egan CE, Butcher BA, Denkers EY: Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int Immunol 2011; 23:317-26
31. Pliyev BK, Sumarokov AB, Buriachkovskaia LI, Menshikov M: Extracellular acidosis promotes neutrophil transdifferentiation to MHC class II-expressing cells. Cell Immunol 2011; 271:214-8
32. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD: Granulocyte-macrophage colonystimulating factor to reverse sepsis-associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009; 180:640-8
33. Singer M: Biomarkers in sepsis. Curr Opin Pulm Med 2013; 19:305-9